Vanguard Asset Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.88M Buy
50,398
+2,045
+4% +$251K ﹤0.01% 890
2026
Q1
$5.7M Buy
+48,353
New +$6.75M ﹤0.01% 878

Other funds holding RGEN

Vanguard Asset Management's RGEN Position: Q2 2026 in Review

Vanguard Asset Management increased its Repligen (RGEN) stake by 4.2% in Q2 2026, buying an estimated $251K and bringing the position to 50,398 shares worth $6.88M. The position accounts for ﹤0.01% of the portfolio, ranked #890.

Vanguard Asset Management first reported a position in RGEN in Q1 2026 and has held it in 2 quarters since. 470 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Vanguard Asset Management held 50,398 shares of Repligen worth $6.88M as of Q2 2026.
  • Vanguard Asset Management bought 2,045 Repligen shares in Q2 2026, an estimated $251K.
  • Repligen made up ﹤0.01% of Vanguard Asset Management's portfolio in Q2 2026, its #890 holding.
  • Vanguard Asset Management first reported a position in Repligen in Q1 2026 and has held it in 2 quarters since.
  • 470 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Vanguard Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.